FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

320276009: Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    463168016 Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1188991018 Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4712231000005118 salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator Is a Salmeterol+fluticasone propionate false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Fluticasone propionate (substance) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salmeterol (substance) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator Is a Product containing fluticasone and salmeterol (medicinal product) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Fluticasone (substance) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Fluticasone propionate (substance) false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator Has manufactured dose form inhalationsdoseringsform false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Salmeterol xinafoate false Inferred relationship Some
    salmeterol 25 µg + fluticasonpropionat 250 µg CFC-fri inhalator Has manufactured dose form Inhaler false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    US English

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start